Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines

The poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is frequently associated to high treatment resistance. Gemcitabine (GEM) alone or in combination is the most used chemotherapy for unresecable PDACs. Here we studied whether modulated electro-hyperthermia (mEHT), a non-invasive complement...

Descripción completa

Detalles Bibliográficos
Autores principales: Forika, Gertrud, Kiss, Eva, Petovari, Gabor, Danko, Titanilla, Gellert, Aron Bertram, Krenacs, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702438/
https://www.ncbi.nlm.nih.gov/pubmed/34955688
http://dx.doi.org/10.3389/pore.2021.1610048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702438/
https://www.ncbi.nlm.nih.gov/pubmed/34955688
http://dx.doi.org/10.3389/pore.2021.1610048

Ejemplares similares